ANNOVIS BIO (ANVS)

US03615A1088 - Common Stock

5.18  -0.27 (-4.95%)

After market: 5.28 +0.1 (+1.93%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
45.04M25.51M14.54M6.64M1.61M
Research and Development
38.79M16.52M8.48M3.05M780.00K
Selling, General, and Administrative Expenses
6.24M9.00M6.06M3.59M830.00K
Operating Income
-45.04M-25.51M-14.54M-6.64M-1.61M
Interest Income/Expense
-11.17M180.00K10.00K20.00K-120.00K
Non Recurring Items
N/A0.0040.00K1.16M740.00K
Income Before Taxes
-56.20M-25.33M-14.49M-5.46M-990.00K
Income Tax
N/AN/A0.000.000.00
Net Income
-56.20M-25.33M-14.49M-5.46M-990.00K
 
Per Share Data
EPS Diluted Total Ops
-6.23-3.10-1.90-0.87-0.14
Non GAAP EPS
-6.13-3.10-1.90N/AN/A
 
Statistics

All data in USD

Charts